Nova Ltd. (NVMI)

Longboard Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	234.87	183.76	136.31	140.21	93.1	47.91
Depreciation & Amortization	19.02	17.38	16.2	14.65	8.93	8.38
Other Amortization	1.2	1.28	1.28	1.28	4.23	0.87
Loss (Gain) From Sale of Investments	-6.64	-7.18	-3	1.67	1.71	-
Stock-Based Compensation	25.18	25.21	18.29	16.65	10.49	6.95
Other Operating Activities	-13.97	3.03	1.75	4.52	-0.75	-1.58
Change in Accounts Receivable	-39.58	-29.05	-1.18	-31.63	-5.13	-11.71
Change in Inventory	-19.01	-23.9	-26	-29.31	-18.46	-16.27
Change in Accounts Payable	10.17	17.51	-7.81	5.14	11.7	3.26
Change in Unearned Revenue	9.84	34.55	11.39	15.24	10.62	2.46
Change in Other Net Operating Assets	22.14	22.4	-17.46	-5.15	18.81	20.19
Operating Cash Flow	229.71	235.27	123.53	119.54	132.26	60.25
Operating Cash Flow Growth	17.16%	90.45%	3.34%	-9.62%	119.51%	48.07%
Capital Expenditures	-23.63	-17.22	-17.19	-21.31	-4.82	-6.44
Cash Acquisitions	-56.36	-	-	-78.47	-	-
Investment in Securities	-54.14	-119.19	-108.14	-0.47	-233.69	-36.02
Investing Cash Flow	-134.13	-136.4	-125.33	-100.26	-238.5	-42.46
Long-Term Debt Issued	-	-	-	-	-	193.59
Long-Term Debt Repaid	-	-18.51	-	-	-	-
Net Debt Issued (Repaid)	-18.51	-18.51	-	-	-	193.59
Issuance of Common Stock	0.16	0.16	0.12	0.09	0.01	0.37
Repurchase of Common Stock	-50	-30	-0.11	-21.42	-	-12.55
Other Financing Activities	-	-	-	-8.48	-	-
Financing Cash Flow	-68.35	-48.35	0.01	-29.81	0.01	181.41
Foreign Exchange Rate Adjustments	3.29	-0.32	-2.36	-4.45	0.62	1.36
Net Cash Flow	30.53	50.21	-4.15	-14.98	-105.61	200.56
Free Cash Flow	206.08	218.05	106.34	98.23	127.45	53.81
Free Cash Flow Growth	14.67%	105.05%	8.27%	-22.93%	136.84%	177.04%
Free Cash Flow Margin	25.53%	32.43%	20.53%	17.21%	30.63%	19.97%
Free Cash Flow Per Share	6.43	6.79	3.31	3.08	4.27	1.86
Cash Income Tax Paid	29.88	29.88	26.84	23.01	13.28	3.98
Levered Free Cash Flow	139.53	176.29	63.68	48.74	108.12	39.54
Unlevered Free Cash Flow	139.13	175.81	63.2	48.26	106.53	39.21
Change in Net Working Capital	27.46	-33.22	36.76	55.44	-21.69	4.4

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q